Figures & data
Figure 2 Bibliometric analysis of publication outputs. (A) The number of annual publications. (B) The distribution of publications by countries/regions.
![Figure 2 Bibliometric analysis of publication outputs. (A) The number of annual publications. (B) The distribution of publications by countries/regions.](/cms/asset/65027ddd-0676-468a-8550-0f279bf18666/dddt_a_12304448_f0002_c.jpg)
Table 1 The Top 10 Countries/Regions and Institutions Involved in Dexmedetomidine
Figure 3 Cooperation between countries/regions on dexmedetomidine. (A) The cooperation networks between different countries/regions; (B) Countries/regions cross-chord charts; (C) Geography map of countries/regions for dexmedetomidine.
![Figure 3 Cooperation between countries/regions on dexmedetomidine. (A) The cooperation networks between different countries/regions; (B) Countries/regions cross-chord charts; (C) Geography map of countries/regions for dexmedetomidine.](/cms/asset/53fb3e9a-e9a3-4758-8c89-f620ac4c7bf2/dddt_a_12304448_f0003_c.jpg)
Figure 4 Cooperation between institutions on dexmedetomidine. (A) The cooperation networks between different institutions; (B) The top 10 institutions in count; (C) The top 10 institutions in centrality.
![Figure 4 Cooperation between institutions on dexmedetomidine. (A) The cooperation networks between different institutions; (B) The top 10 institutions in count; (C) The top 10 institutions in centrality.](/cms/asset/96c57dd4-3efc-4897-b42f-e85b00a8a685/dddt_a_12304448_f0004_c.jpg)
Table 2 The Top 10 Authors and Cited Authors in Dexmedetomidine
Figure 5 Authors analysis on dexmedetomidine. (A) The cooperation networks between different authors; (B) The density visualization map of authors based on VOSviewer; (C) The cooperation networks between different cited authors.
![Figure 5 Authors analysis on dexmedetomidine. (A) The cooperation networks between different authors; (B) The density visualization map of authors based on VOSviewer; (C) The cooperation networks between different cited authors.](/cms/asset/2ebc239b-b43a-4526-ab2a-f1f335ffbd51/dddt_a_12304448_f0005_c.jpg)
Table 3 According to Bradford’s Law, the 1,186 Journals in Dexmedetomidine were Classified into Zones 1–3
Figure 6 Journals analysis on dexmedetomidine. (A) Journals output trends within the top 5 from 2014 to 2023; (B) Core journals by Bradford’s law.
![Figure 6 Journals analysis on dexmedetomidine. (A) Journals output trends within the top 5 from 2014 to 2023; (B) Core journals by Bradford’s law.](/cms/asset/eab713f1-4afe-4b2c-9607-e8cdaf554def/dddt_a_12304448_f0006_c.jpg)
Table 4 The Top 10 Cited Journals in Dexmedetomidine
Figure 7 Cited journals analysis on dexmedetomidine. (A) The network map of cited journals; (B) The top 10 cited journals in count; (C) The top 10 cited journals in centrality; (D) The dual-map overlay of citing of citation relationship of articles, with citing journal on the left, and the cited journal on the right. The colored path represented the citation relationship.
![Figure 7 Cited journals analysis on dexmedetomidine. (A) The network map of cited journals; (B) The top 10 cited journals in count; (C) The top 10 cited journals in centrality; (D) The dual-map overlay of citing of citation relationship of articles, with citing journal on the left, and the cited journal on the right. The colored path represented the citation relationship.](/cms/asset/dcbd8b38-0d37-4ee8-9616-33bc0784a3fd/dddt_a_12304448_f0007_c.jpg)
Table 5 The Top 10 Cited References in Dexmedetomidine
Figure 8 Cited references analysis on dexmedetomidine. (A) The network map of cited references; (B) The clustering of cited references; (C) The top 30 cited references with the strongest citation bursts.
![Figure 8 Cited references analysis on dexmedetomidine. (A) The network map of cited references; (B) The clustering of cited references; (C) The top 30 cited references with the strongest citation bursts.](/cms/asset/42cf166e-4321-42aa-a4b6-46ea73335585/dddt_a_12304448_f0008_c.jpg)
Table 6 Top 10 Productive WOS Categories in Dexmedetomidine, Ranked by the Number of Publications
Figure 9 R bibliometrics-thematic evolution tool traces the progression of research themes in the realm of dexmedetomidine, spanning from 2014 to 2023.
![Figure 9 R bibliometrics-thematic evolution tool traces the progression of research themes in the realm of dexmedetomidine, spanning from 2014 to 2023.](/cms/asset/3426b239-574b-4ec8-a920-d3c04254a447/dddt_a_12304448_f0009_c.jpg)
Figure 10 Keywords analysis on dexmedetomidine. (A) The network map of the co-occurrence keywords; (B) Clusters of keywords; (C) Timeline view of keywords analysis; (D) The top 20 keywords with the strongest citation bursts.
![Figure 10 Keywords analysis on dexmedetomidine. (A) The network map of the co-occurrence keywords; (B) Clusters of keywords; (C) Timeline view of keywords analysis; (D) The top 20 keywords with the strongest citation bursts.](/cms/asset/4a71ed6b-277a-4d6d-a55a-1000aad505e1/dddt_a_12304448_f0010_c.jpg)
Data Sharing Statement
The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.